Stay updated with breaking news from Cell Line. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers evaluated the clinical and genetic characteristics of acute myeloid leukemia (AML) patients with a mutant Ikaros zinc finger protein 1 (IKZF1).
BERLIN, Germany, January 26, 2023 / B3C newswire / -- ProBioGen today announced that a Novartis clinical candidate using its antibody-dependent cellular cytotoxicity (ADCC) technology, GlymaxX, has reached Phase III.ProBioGen's mission is to contribute towards the development of medicines against complex diseases. T...
Contract development and manufacturing organization (CDMO) that provide services for processing large molecule or biologics drug substances are referred to...
In a recent study posted to bioRxiv* preprint server, researchers at Ohio State University examined the degree of neutralizing antibody (nAb) evasion by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron XBB.1.5, CA.3.1, and CH.1.1 subvariants.
Berkeley Lights, Inc., a life sciences tools company, today announced the launch of the Beacon Select™, the company's new optofluidic system for cell line development (CLD).